annual FCF:
-$399.80M+$15.95M(+3.84%)Summary
- As of today (June 21, 2025), CYTK annual free cash flow is -$399.80 million, with the most recent change of +$15.95 million (+3.84%) on December 31, 2024.
- During the last 3 years, CYTK annual FCF has fallen by -$208.40 million (-108.89%).
- CYTK annual FCF is now -1229.81% below its all-time high of $35.39 million, reached on December 31, 2016.
Performance
CYTK Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$137.28M-$70.42M(-105.33%)Summary
- As of today (June 21, 2025), CYTK quarterly free cash flow is -$137.28 million, with the most recent change of -$70.42 million (-105.33%) on March 1, 2025.
- Over the past year, CYTK quarterly FCF has dropped by -$7.77 million (-6.00%).
- CYTK quarterly FCF is now -278.34% below its all-time high of $76.97 million, reached on December 31, 2016.
Performance
CYTK quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$407.57M-$7.77M(-1.94%)Summary
- As of today (June 21, 2025), CYTK TTM free cash flow is -$407.57 million, with the most recent change of -$7.77 million (-1.94%) on March 1, 2025.
- Over the past year, CYTK TTM FCF has increased by +$15.00 million (+3.55%).
- CYTK TTM FCF is now -1251.78% below its all-time high of $35.39 million, reached on December 31, 2016.
Performance
CYTK TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
CYTK Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.8% | -6.0% | +3.5% |
| 3 y3 years | -108.9% | -394.6% | -122.7% |
| 5 y5 years | -327.5% | -340.3% | -317.9% |
CYTK Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -108.9% | +3.8% | -394.6% | at low | -122.7% | +8.0% |
| 5 y | 5-year | <-9999.0% | +3.8% | -401.1% | at low | <-9999.0% | +8.0% |
| alltime | all time | -1229.8% | +3.8% | -278.3% | at low | -1251.8% | +8.0% |
CYTK Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$137.28M(+105.3%) | -$407.57M(+1.9%) |
| Dec 2024 | -$399.80M(-3.8%) | -$66.86M(-34.6%) | -$399.80M(-1.8%) |
| Sep 2024 | - | -$102.20M(+1.0%) | -$407.05M(+1.4%) |
| Jun 2024 | - | -$101.23M(-21.8%) | -$401.27M(-5.0%) |
| Mar 2024 | - | -$129.51M(+74.7%) | -$422.57M(+1.6%) |
| Dec 2023 | -$415.75M(+33.7%) | -$74.11M(-23.1%) | -$415.75M(-6.2%) |
| Sep 2023 | - | -$96.42M(-21.3%) | -$443.03M(+1.4%) |
| Jun 2023 | - | -$122.52M(-0.1%) | -$436.98M(+7.7%) |
| Mar 2023 | - | -$122.69M(+21.0%) | -$405.79M(+30.5%) |
| Dec 2022 | -$310.85M(+62.4%) | -$101.39M(+12.2%) | -$310.85M(+14.3%) |
| Sep 2022 | - | -$90.37M(-1.1%) | -$271.95M(+15.2%) |
| Jun 2022 | - | -$91.33M(+229.1%) | -$236.05M(+29.0%) |
| Mar 2022 | - | -$27.75M(-55.6%) | -$183.00M(-4.4%) |
| Dec 2021 | -$191.39M(+8975.1%) | -$62.49M(+14.7%) | -$191.39M(+129.7%) |
| Sep 2021 | - | -$54.47M(+42.3%) | -$83.31M(+388.2%) |
| Jun 2021 | - | -$38.29M(+5.9%) | -$17.06M(+141.1%) |
| Mar 2021 | - | -$36.15M(-179.3%) | -$7.08M(+235.6%) |
| Dec 2020 | -$2.11M(-97.7%) | $45.59M(+287.2%) | -$2.11M(-96.9%) |
| Sep 2020 | - | $11.78M(-141.6%) | -$68.06M(-32.7%) |
| Jun 2020 | - | -$28.30M(-9.2%) | -$101.11M(+3.7%) |
| Mar 2020 | - | -$31.18M(+53.1%) | -$97.54M(+4.3%) |
| Dec 2019 | -$93.53M(-8.4%) | -$20.36M(-4.3%) | -$93.53M(+9.1%) |
| Sep 2019 | - | -$21.27M(-14.0%) | -$85.70M(-11.7%) |
| Jun 2019 | - | -$24.73M(-9.0%) | -$97.02M(-2.2%) |
| Mar 2019 | - | -$27.16M(+116.7%) | -$99.20M(-2.8%) |
| Dec 2018 | -$102.10M(-2.4%) | -$12.54M(-61.5%) | -$102.10M(-10.8%) |
| Sep 2018 | - | -$32.59M(+21.1%) | -$114.42M(+6.2%) |
| Jun 2018 | - | -$26.91M(-10.5%) | -$107.76M(-4.1%) |
| Mar 2018 | - | -$30.07M(+21.0%) | -$112.37M(+7.4%) |
| Dec 2017 | -$104.64M(-395.7%) | -$24.85M(-4.2%) | -$104.64M(+3623.7%) |
| Sep 2017 | - | -$25.93M(-17.7%) | -$2.81M(-126.3%) |
| Jun 2017 | - | -$31.52M(+41.1%) | $10.70M(-65.5%) |
| Mar 2017 | - | -$22.33M(-129.0%) | $30.98M(-12.4%) |
| Dec 2016 | $35.39M(+718.9%) | $76.97M(-719.4%) | $35.39M(-168.4%) |
| Sep 2016 | - | -$12.43M(+10.6%) | -$51.73M(+4.1%) |
| Jun 2016 | - | -$11.23M(-37.3%) | -$49.71M(+3.9%) |
| Mar 2016 | - | -$17.93M(+76.7%) | -$47.84M(-1207.0%) |
| Dec 2015 | $4.32M(-109.4%) | -$10.15M(-2.4%) | $4.32M(-29.0%) |
| Sep 2015 | - | -$10.40M(+11.1%) | $6.09M(-11.4%) |
| Jun 2015 | - | -$9.36M(-127.4%) | $6.88M(+6.8%) |
| Mar 2015 | - | $34.23M(-508.6%) | $6.44M(-114.0%) |
| Dec 2014 | -$45.95M | -$8.38M(-12.9%) | -$45.95M(-8.6%) |
| Sep 2014 | - | -$9.62M(-1.9%) | -$50.25M(+65.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | -$9.80M(-46.0%) | -$30.40M(+116.9%) |
| Mar 2014 | - | -$18.16M(+43.2%) | -$14.02M(+69.7%) |
| Dec 2013 | -$8.26M(-75.4%) | -$12.68M(-223.8%) | -$8.26M(+199.1%) |
| Sep 2013 | - | $10.24M(+55.6%) | -$2.76M(-87.4%) |
| Jun 2013 | - | $6.58M(-153.1%) | -$21.93M(-41.1%) |
| Mar 2013 | - | -$12.40M(+72.6%) | -$37.21M(+10.9%) |
| Dec 2012 | -$33.56M(-27.1%) | -$7.18M(-19.5%) | -$33.56M(-10.1%) |
| Sep 2012 | - | -$8.92M(+2.5%) | -$37.35M(-1.2%) |
| Jun 2012 | - | -$8.71M(-0.5%) | -$37.79M(-9.4%) |
| Mar 2012 | - | -$8.75M(-20.2%) | -$41.73M(-9.4%) |
| Dec 2011 | -$46.04M(+1.6%) | -$10.97M(+17.1%) | -$46.04M(+4.1%) |
| Sep 2011 | - | -$9.37M(-26.0%) | -$44.25M(-2.4%) |
| Jun 2011 | - | -$12.65M(-3.1%) | -$45.33M(-1.5%) |
| Mar 2011 | - | -$13.05M(+42.2%) | -$46.02M(+1.5%) |
| Dec 2010 | -$45.32M(-676.2%) | -$9.18M(-12.2%) | -$45.32M(+6.1%) |
| Sep 2010 | - | -$10.45M(-21.6%) | -$42.70M(-2.7%) |
| Jun 2010 | - | -$13.33M(+7.9%) | -$43.89M(-684.3%) |
| Mar 2010 | - | -$12.36M(+88.5%) | $7.51M(-4.5%) |
| Dec 2009 | $7.87M(-112.7%) | -$6.56M(-43.7%) | $7.87M(+491.0%) |
| Sep 2009 | - | -$11.64M(-130.6%) | $1.33M(-136.2%) |
| Jun 2009 | - | $38.07M(-417.0%) | -$3.68M(-93.8%) |
| Mar 2009 | - | -$12.01M(-8.3%) | -$59.79M(-3.5%) |
| Dec 2008 | -$61.99M(+1013.3%) | -$13.09M(-21.4%) | -$61.99M(-2.1%) |
| Sep 2008 | - | -$16.65M(-7.7%) | -$63.33M(+10.8%) |
| Jun 2008 | - | -$18.04M(+27.1%) | -$57.15M(+8.1%) |
| Mar 2008 | - | -$14.20M(-1.6%) | -$52.84M(+849.0%) |
| Dec 2007 | -$5.57M(-89.4%) | -$14.43M(+37.9%) | -$5.57M(-6.3%) |
| Sep 2007 | - | -$10.47M(-23.8%) | -$5.94M(-33.8%) |
| Jun 2007 | - | -$13.74M(-141.5%) | -$8.97M(+18.8%) |
| Mar 2007 | - | $33.07M(-323.4%) | -$7.55M(-85.6%) |
| Dec 2006 | -$52.54M(+28.3%) | -$14.81M(+9.7%) | -$52.54M(+9.4%) |
| Sep 2006 | - | -$13.50M(+9.6%) | -$48.03M(+9.9%) |
| Jun 2006 | - | -$12.32M(+3.4%) | -$43.69M(-0.2%) |
| Mar 2006 | - | -$11.91M(+15.7%) | -$43.79M(+6.9%) |
| Dec 2005 | -$40.95M(+15.6%) | -$10.30M(+12.4%) | -$40.95M(-4.1%) |
| Sep 2005 | - | -$9.16M(-26.3%) | -$42.68M(-0.6%) |
| Jun 2005 | - | -$12.42M(+36.9%) | -$42.93M(+14.9%) |
| Mar 2005 | - | -$9.07M(-24.6%) | -$37.36M(+5.4%) |
| Dec 2004 | -$35.43M(+5.0%) | -$12.03M(+28.0%) | -$35.43M(+51.4%) |
| Sep 2004 | - | -$9.40M(+37.3%) | -$23.40M(+67.2%) |
| Jun 2004 | - | -$6.85M(-4.2%) | -$14.00M(+95.8%) |
| Mar 2004 | - | -$7.15M | -$7.15M |
| Dec 2003 | -$33.75M(+16.9%) | - | - |
| Dec 2002 | -$28.87M | - | - |
FAQ
- What is Cytokinetics Incorporated annual free cash flow?
- What is the all time high annual FCF for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual FCF year-on-year change?
- What is Cytokinetics Incorporated quarterly free cash flow?
- What is the all time high quarterly FCF for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly FCF year-on-year change?
- What is Cytokinetics Incorporated TTM free cash flow?
- What is the all time high TTM FCF for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated TTM FCF year-on-year change?
What is Cytokinetics Incorporated annual free cash flow?
The current annual FCF of CYTK is -$399.80M
What is the all time high annual FCF for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual free cash flow is $35.39M
What is Cytokinetics Incorporated annual FCF year-on-year change?
Over the past year, CYTK annual free cash flow has changed by +$15.95M (+3.84%)
What is Cytokinetics Incorporated quarterly free cash flow?
The current quarterly FCF of CYTK is -$137.28M
What is the all time high quarterly FCF for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly free cash flow is $76.97M
What is Cytokinetics Incorporated quarterly FCF year-on-year change?
Over the past year, CYTK quarterly free cash flow has changed by -$7.77M (-6.00%)
What is Cytokinetics Incorporated TTM free cash flow?
The current TTM FCF of CYTK is -$407.57M
What is the all time high TTM FCF for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high TTM free cash flow is $35.39M
What is Cytokinetics Incorporated TTM FCF year-on-year change?
Over the past year, CYTK TTM free cash flow has changed by +$15.00M (+3.55%)